ANEMIA AT PATIENTS WITH CHRONIC HEPATITIS C, WHO ARE RECEIVING COMBINED ANTI-VIRUS THERAPY. THE SYMPTOMS, AND THE FEATURES OF PATHOGENESIS
1
Dontsov D.V. 1Ambalov J.M. 1Proydakov M.A. 1Vinogradova M.V. 1Kislov E.O. 1
1 Rostov State Medical University
The patients with chronic hepatitis C, are receiving combined anti-virus therapy, have frequently the positive virological result. But some patients during the treatment can receive the development of adverse effects. A special place in this case occupies hematological syndromes. In this work we have studied some features of pathogenesis from anemia at patients with chronic hepatitis C, who receives combined anti-virus therapy. We had been executed special researches: automatic hematological the analysis, electronic microscopy, definition of activity of some enzymes and concentration of markers defeats of lipids by superoxide radicals, a level of antibodies against erythrocytes, concentration of human erythropoietin, and the DNA polymorphism of genes SOD2, CAT, GPX4. There are 224 patients, who are receiving combined anti-virus therapy of chronic hepatitis C, in this research.
Библиографическая ссылка
Донцов Д.В., Амбалов Ю.М., Пройдаков М.А., Виноградова М.В., Кислов Е.О. АНЕМИЯ У БОЛЬНЫХ ХРОНИЧЕСКИМ ГЕПАТИТОМ С, ПОЛУЧАЮЩИХ КОМБИНИРОВАННУЮ ПРОТИВОВИРУСНУЮ ТЕРАПИЮ. КЛИНИЧЕСКИЕ ПРОЯВЛЕНИЯ. ОСОБЕННОСТИ ПАТОГЕНЕЗА // Научное обозрение. Медицинские науки. 2015. № 1.
С. 162-163;
URL:
https://science-medicine.ru/en/article/view?id=779 (дата обращения: 29.05.2026).